OssDsign AB

Equities

OSSD

SE0012570448

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:29:48 2024-04-29 am EDT			5-day change	1st Jan Change
9.75 ^SEK	+5.52%		+4.39%	+21.88%

Apr. 15	Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.	CI
Apr. 02	OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products	MT

An Unknown buyer acquired 7.6% stake in OssDsign AB (OM:OSSD).

November 29, 2023

An Unknown buyer acquired 7.6% stake in OssDsign AB (publ) (OM:OSSD) on November 30, 2023.

An Unknown buyer completed the acquisition of 7.6% stake in OssDsign AB (publ) (OM:OSSD) on November 30, 2023.

Latest news about OssDsign AB

Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.	Apr. 14	CI
OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products	Apr. 02	MT
OssDsign AB Wins Long-Term Agreement with Premier, Inc	Apr. 02	CI
Sweden's OssDsign Names Chief Technical Officer	Feb. 29	MT
OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer	Feb. 29	CI
Transcript : OssDsign AB, Q4 2023 Earnings Call, Feb 06, 2024	Feb. 06
OssDsign AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 06	CI
OssDsign AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 06	CI
OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion	Jan. 24	CI
OssDsign AB Reports Exceptional Data from the Clinical Study TOP FUSION	Jan. 09	CI
Ossdsign AB Reports Revenues for the Period October - November 2023	Dec. 06	CI
Ossdsign AB Provides Revenue Guidance for the Fourth Quarter of 2023	Dec. 06	CI
SEB Venture Capital Sells Full Stake in OssDsign	Nov. 30	MT
An Unknown buyer acquired 7.6% stake in OssDsign AB (OM:OSSD).	Nov. 29	CI
Transcript : OssDsign AB, Q3 2023 Earnings Call, Nov 21, 2023	Nov. 21
OssDsign AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 21	CI
Transcript : OssDsign AB - Special Call	23-09-27
OssDsign to Switch Focus to Orthobiologics Business in US	23-09-27	MT
OssDsign Raises SEK150 Million via Share Issue; Stock Rises	23-09-27	MT
OssDsign AB Announces All Activities Pertaining to the Patient-Specific Cranial Implant Business Will Be Discontinued in A Responsible Manner by the End of December 2023	23-09-26	CI
OssDsign Receives FDA Clearance for A New Major Indication	23-09-19	CI
OssDsign Wins US FDA Nod for Expanded Use of Nanosynthetic Bone Graft in Interbody Cages	23-09-18	MT
Transcript : OssDsign AB, Q2 2023 Earnings Call, Aug 22, 2023	23-08-22
OssDsign AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 29-MAY-2023.	23-05-28	CI

Chart OssDsign AB

Duration

Period

More charts

Company Profile

OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for OssDsign AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
OSSDSIGN AB	+21.88%	82.3M
STRYKER CORPORATION	+13.16%	128B
SMITH & NEPHEW PLC	-8.76%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.60%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+19.75%	7.19B
GLAUKOS CORPORATION	+22.28%	4.99B
AXONICS, INC.	+7.55%	3.4B
ENOVIS CORPORATION	-0.21%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-4.80%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-4.72%	2B

Medical Devices & Implants